What is Autism?
Autism spectrum disorder (ASD) is a pervasive developmental disorder characterised by a triad of symptoms; impaired social skills, rigid communication style & characteristic repetitive and ritualised behaviours. Although, it is considered a lifelong condition, one’s impairments can significantly improve with appropriate awareness, support and, where required, intervention.
ASD could be considered an umbrella term for autistic conditions as seen in the ICD and DSM diagnostic manuals. ICD-10 outlines eight conditions under F84: childhood autism, atypical autism, Rett’s syndrome, other childhood disintegrative disorder, overactive disorder associated with mental retardation and stereotyped movements, Asperger’s syndrome, other pervasive developmental disorders and pervasive developmental disorder, unspecified. DSM-IV set out five conditions within chapter one’s description of pervasive developmental disorders: autistic disorder, Rett’s disorder, childhood disintegrative disorder, Asperger’s syndrome and pervasive developmental disorder - not otherwise specified, including atypical autism.
The most recent version of the DSM diagnostic criteria, DSM-5 combined autism, Asperger’s syndrome and pervasive developmental disorder into a single diagnosis and changed the name of this group from ‘pervasive developmental disorders’ to ‘autism spectrum disorder’ (American Psychiatric Association, 2013). Although the category remains broad, DSM-5 no longer provides differing criteria for each condition, instead a single set of criteria can be used to diagnose ASD.
The ICD-10 and DSM-5 criteria:
Diagnostic Criteria for Subtypes of Autism Spectrum Disorder
International Classification of Diseases-10 (World Health Organisation, 1992)
‘A. Abnormal or impaired development is evident before the age of 3 years in at least one of the following areas:
1. receptive or expressive language as used in social communication.
2. the development of selective social attachment or of reciprocal social interaction.
3. functional or symbolic play.
B. A total of at least six symptoms from (1), (2) and (3) must be present, with at least two from (1) and at least one from each of (2) and (3)
1. Qualitative Impairment in social Interaction are manifest in at least two of the following areas:
a) failure adequately to use eye-to-eye gaze, facial expression, body posture and gestures to regulate social interaction.
b) failure to develop (in a manner appropriate for mental age, and despite ample opportunities) peer relationship that involve a mutual sharing of interests, activities and emotions.
c) lack of socio-emotional reciprocity as shown by an impairment or deviant response to other people's emotions; or lack of modulation of behaviour according to social context; or a weak integration of social, emotional and communicative behaviours.
d) lack of spontaneous seeking to share enjoyment, interests or achievements with other people (e.g. a lack of showing, bringing or pointing out to other people objects of interest to the individual).
2. Qualitative abnormalities in communication as manifest in at least one of the following areas:
a) delay in or total lack of development of spoken language that is not accompanied by an attempt to compensate through the use of gestures or mime as an alternative mode of communication (often preceded by a lack of communicative babbling).
b) relative failure to initiate or sustain conversational Interchange (at whatever level of language skill is present) in which there is reciprocal responsiveness to the communications of the other person.
c) stereotyped and repetitive use of language or idiosyncratic use of words or phrases.
d) lack of varied spontaneous make-believe play or (when young) social imitative play.
3. Restricted, repetitive and stereotypes patterns of behaviour, interests and activities are manifested in at least one of the following:
a) an encompassing preoccupation with one or more stereotyped and restricted patterns of interest that are abnormal in content of focus, or one or more interests that are abnormal in their intensity and circumscribed nature though not in their content or focus.
b) apparently compulsive adherence to specific non-functional routines and rituals stereotyped and repetitive motor mannerisms that involve either hand or finger flapping or twisting or complex whole body movements.
d) preoccupations with part-objects of non-functional elements of play materials (such as their order, the feel of their surface or the noise or vibration they generate).
The clinical picture is not attributable to the other varieties of pervasive developmental disorders, specific development disorder of receptive language with secondary socio-emotional problems, reactive attachment disorder or disinhibited attachment disorder, mental retardation with some associated emotional or behavioural disorders, schizophrenia of unusually early onset and Rett’s syndrome’.
A. Abnormal or impaired development is evident at or after the age of 3 years.
B. There is insufficient demonstrable abnormalities in one or two of the three areas of psychopathology required for the diagnosis of childhood autism (namely reciprocal social interactions, communication or restrictive, stereotyped, repetitive behaviours).
C. Atypical autism constitutes a meaningfully separate condition from childhood autism.
A. Diagnostic criteria 1 - 3 of B are fulfilled for childhood autism.
B. No evidence of general delay or retardation in language or cognitive development.
C. Generally associated with normal intelligence.
Diagnostic and Statistical Manual of Mental Disorders-5 (American Psychiatric Association, 2013)
Autism spectrum disorder (ASD)
A. Persistent deficits in social communication and social interaction across multiple contexts, as manifested by the following, currently or by history:
· Deficits in socio-emotional reciprocity.
· Deficits in non-verbal communicative behaviours used for social interaction.
· Deficits in developing, maintaining and understanding relationships.
B. Restricted, repetitive patterns of behaviour, interests, or activities, as manifested by at least two of the following, currently or by history:
· Stereotyped or repetitive motor mannerisms, use of objects or speech.
· Insistence on sameness, inflexible adherence to routines or ritualised patterns of verbal or non-verbal behaviour.
· Highly restricted, fixated interests that are abnormal in intensity or focus.
· Hyper- or hypo- reactivity to sensory input or unusual interest in sensory aspects of the environment.
C. Symptoms must be present in early developmental period.
D. Symptoms cause clinically significant impairment in social, occupational or other important areas of current functioning.
E. These disturbances are not better explained by intellectual or global developmental delay.
Autism and Physical Illness
Erroneously early researchers thought that individuals with autism spectrum disorder did not perceive pain and did not communicate their distress; perhaps lacking the ‘social inclination’ to do so (Lainhart 1999). In the mid 2000’s, researchers hypothesised that those with ASD actually have difficulty reporting physical ailments and instead express pain and physical distress as agitation and / or behavioural disturbance (Russell 2005). Although current literature on physical illness in adults with ASD is sparse, a 2016 study by O’Rourke revealed a prevalence rate of 84% for at least one physical health condition among adults with ASD. Atopy was the most commonly diagnosed condition and epilepsy was also notably more common in those with ASD.
Although historically considered almost diagnostic for ASD, eating disturbance is now known to occur in approximately 25% of adults with ASD. Restricted dietary repertoire was most commonly reported, followed by reduced appetite, picky eating, eating only a single meal per day, only eating when alone, unhealthy dietary choices, binge-eating and overeating (O’Rourke 2016). Available research in relation to gastrointestinal disease in ASD is varied and controversial. However, available literature would suggest that previously reported higher rates of gastrointestinal disease in individuals with ASDs were greatly exaggerated.
Sleep is a relatively well-researched topic in ASD. In fact, it has been referred to as the second most researched area of ASD comorbidity, only surpassed by epilepsy (Mannion 2014). Sleep studies in normal IQ infants with ASD have shown that 90% of sleep difficulties start at an early age including difficulty falling asleep, more frequent night waking and early morning waking (Øyane 2005). Studies of school-age children with ASD have noted difficulties with bedtime resistance, increased sleep latency, poor sleep maintenance, early morning waking, reduced sleep time and quality, increased night waking and irregular sleep patterns in 50% - 80% of subjects (Øyane 2005, Limoges 2005, Canitano 2007, Reynolds 2011). Insomnia rates of 36% have been reported in the child population, most commonly middle insomnia, followed by initial insomnia (Mattila 2010). Adolescent and young adult studies also identify a high prevalence of sleep disorders (80%) including low sleep efficiency, short total sleep time, long sleep latency, more frequent shifts into REM sleep from waking and increased REM sleep disruption (Ghaziuddin 2002a, Øyane 2005).
In general, it is acknowledged that motor skill deficits are frequently observed in patients with ASD with a prevalence of 21% - 100% (Gowen 2012). Asperger described awkwardness as typical in autistic psychopathy (Wing 2002a, Barnhill 2007, Raja 2009) while Kanner (1943) noted that several children under his care were somewhat clumsy in gait with gross motor deficits but all were skilled in fine motor movements. Although not included in the DSM-5 diagnostic criteria, clumsiness is commented upon in the ICD-10’s description of Asperger’s syndrome (World Health Organisation 1992). Wing (1981) observed poorly co-ordinated movements, odd posture and abnormal gait while more recently Vannucchi (2014) described clumsiness and illegible handwriting as atypical features of Asperger’s syndrome and Van Wijngaarden-Cremers (2014) noted clumsiness in the case of a 14 year old girl with Asperger’s syndrome and comorbid drug addiction.
Autism and Mental Illness
Increasingly autism spectrum disorder is associated with a higher prevalence of mental illness than seen in the general population (Stewart 2006, Nylander 2008, Raja 2008). Roy (2015) noted a lifetime prevalence of one or more comorbid psychiatric illness in 70% of adults with High-functioning ASD.
Rates of anxiety spectrum disorders are higher in the ASD population compared to the general population, including obsessive compulsive disorder, generalised anxiety disorder, social phobia and agoraphobia (O’Rourke 2016).
Rates for mood disorders range from 24% - 53% (Ketelaars 2008, Hofvander 2009, Stunz 2014). Lifetime prevalence of major depressive disorder is 70% - 77%, recurrent depression 50%, current depressive episode 30% and dysthymia 8% (Cath 2008, Lugnegård 2011, Joshi 2013).
O’Rourke (2016) identified a prevalence rate of 25% for deliberate self-harm and a rate of 16% for self-injurious behaviour in autistic adults.
Schizoid, schizotypal, paranoid, obsessive-compulsive, anxious-avoidant and dependent personality styles are more common in autistic adults than in the general population (Anckarsäter 2006).
Schizophrenia has a lifetime prevalence of 0.30% - 0.87% in the general population (Perälä 2007, Van Os 2009). Rates among those with ASD are less clearly defined. As early as the 1940’s, Asperger noted that only one of the 200 cases he studied developed schizophrenia (Wing 1981). Volkmar and Cohen (1991) restarted the debate on comorbidity between ASD and schizophrenia when they identified only a single patient with schizophrenia from 163 cases assessed. Volkmar and Cohen (1991) described schizophrenia as rare in those with ASD, ‘no more commonly observed together than would be expected by chance’.
While research on eating disorder in autistic adults is scarce, it is agreed that ASD is over-represented in the anorexia nervosa population (Oldershaw 2011). A single study was identified which showed a prevalence rate of 5% for comorbid ASD and eating disorder. The comparable occurrence rate in the general population is anorexia nervosa 0.9% and bulimia nervosa 1.5% for women and anorexia nervosa 0.3% and bulimia nervosa 0.5% for men (Hudson 2007).s
New Autism Assessment
Why Assess for Autism?
Wellbeing, ‘the state of being happy, healthy or prosperous is recognised as lower for those with ASD compared to neurotypical counterparts particularly in relation to physical, psychological, social supports and peers (Biggs 2016, Merriman-Webster 2018). Poorer wellbeing is particularly evident at times of transition, including the transition to adulthood, when significant attention needs to be focused on ensuring adequate services, supports and relationships to facilitate a successful outcome (Biggs 2016). Wellbeing and similarly quality of life is difficult to accurately quantify but factors which are known to impact on outcome in those with ASD include ‘physical wellbeing, material wellbeing, interpersonal relationships, social inclusion, personal development, self-determination, emotional wellbeing and rights’ (Plimley 2007, p.207).
It is essential that supports and services which can optimise wellbeing and quality of life are provided early in a child’s life and for those who receive a late diagnosis as soon as possible after diagnosis. Needs change as a person ages, the needs of a child differ to those of a teenage, an adult and an older adult. Needs also change at times of transition such as moving from Montessori to national school to secondary school to University or work, when a relationship ends or a person is bereaved or when an individual struggles as peers or siblings move to another life stage such as relationships, marriage or having children while they themselves may not.
The majority of autistic adults are single & living with their parents, up to 91% are unemployed, up to 95% have been bullied and up to 40% have been sexually or financially exploited (O’Rourke 2016). Knapp, Romeo and Beecham (2009) showed the estimated lifetime cost for an adult with ASD to range from £800,000 to £1,230,000. To address these barriers to positive outcomes, supports and services should be person-centred, unified across medical and social care models, available when needed and available on an ongoing basis from infancy to old age (Plimley 2007).
Evidence-Based Assessment According to International Best-Practice Guidelines
Autism spectrum disorder can be behaviourally defined by diagnostic criteria specifying pervasive qualitative differences in social and communication skills and behaviour. However, as yet, there are no definitive medical tests, biochemical, neuroimaging or otherwise to detect autism spectrum disorder. Hence, diagnosis relies heavily on detailed history and observation of behaviour by skilled clinicians using the ICD-10 and / or DSM-5 criteria.
International Assessment Guidelines: NICE and Sign recommend diagnosis by a minimum of two clinical disciplines trained in assessment and diagnosis of ASD.
An ASD assessment can include:
1. Screening - IQ appropriate tools for patient and carer.
2. Clinical History - based on ICD or DSM Diagnostic criteria.
3. Observational assessment - clinical and ADOS-2.
4. History of functioining outside the clinical setting.
5. Developmental History: both clinical history and ADI-R.
6. Individual profiling e.g.IQ, communication skills, adaptive skills, sensory profile where relevant.
7. Investigations e.g. Genetic testing, audiology, eyetest, MRI Brain, EEG where relevant.
8. Assessment for comorbid physical and/or psychiatric illness.
Note: A recent systematic review by Wigham et al (Autism 2018; Feb 1:1-19) advises caution when using screening questionnaires with patients with a comorbid mental illness; interpretation is less reliable as screening tools are less sensitive and specialist discrimination between autism and a mental illness is required.
The Autism Assessment at Core Clinical
At the beginning of an ASD clinical assessment, we ask you and a family member, nominated by you, to complete a number of screening questionnaires which we use to triage your information towards a more efficient assessment. This information can also assist in developing an individual profile for each person attending our service allowing for a more informative feedback session following review.
Each New Autism Assessment at Core Clinical is undertaken in a multidisciplinary format in line with international best practice. Both a psychiatrist and psychologist will interview you and your nominated family member(s) to ensure the assessment is appropriately comprehensive. We use structured interview, clinical observation and evidence-based diagnostic tools to reach a diagnosis. The assessment is expected to last 3 to 4 hours with each clinician.
Consensus Meeting, Feedback and Recommendations
Before reaching a clinical decision in relation to a person’s diagnosis, the multidisciplinary team engage in a consensus meeting. This meeting combines information gathered over the course of the assessments to allow a multidisciplinary diagnostic formulation and the development of individualised recommendations. As a team we will meet with you and your nominated family member(s) to discuss our findings and outline our recommendations. We endeavour to complete this process on the second day of your assessment. Where this is not possible due to factors such as missing information, co-existing disorders or a requirement for further assessment (e.g. IQ assessment) we will explain the reasons why and offer you options as to how to proceed.
It is our preferred practice to meet with each individual that receives a new autism diagnosis within 4-6 weeks of their assessment appointment. This follow-up session is to provide space for further discussion of the diagnosis and to address questions the individual may have.
Previous Autism Diagnosis
If you have previously had an autism diagnostic assessment:
If you have a previous diagnosis of autism and wish to attend Core Clinical for psychotherapy with our clinical psychologist, we are happy to receive a letter or email detailing your query.
For the remainder of 2019, we are no longer accepting new referrals for psychiatric consultation / treatment. This applies only to our autism service, our ADHD psychiatry service is unaffected. We are saddened by this development and hope we will be in a position to revise this in 2020.
To facilitate a consultation with our psychologist, we will require a copy of your previous diagnostic report. This is in line with Irish Guidelines for practice, as per a recent HSE Review of Irish Autism Services: Report of the Review of the Irish Health Services for Individuals with Autism Spectrum Disorders, 2018. This paper states that: 'As well as assisting in the provision of a diagnosis, assessment tools should identify strengths, skills and impairments to inform post-diagnostic needs-based care plans'.
To understand your autism-related needs, we require this report which will contain information from the clinicians, describing your background, autistic difficulties, match these difficulties to the diagnostic criteria (DSM IV/5 or ICD-10) and contain the results of a structured assessment tool (which research has proven can reliably detect autism, of which there are 2, the ADOS and ADI-R).
Many people will have received a copy of this report at the time of diagnostic assessment. If you do not have a copy, we suggest you contact the service who completed your assessment or ask your GP if they have a copy.
This report can be sent in at the same time as your referral letter (by your GP) or you can send it yourself to firstname.lastname@example.org and Margaret, our secretary, will ensure it is linked to your referral information.
What is ADHD?
Attention Deficit Hyperactivity Disorder (ADHD) is a behavioural disorder that is characterised by difficulties in concentrating, being overactive and acting without thinking. If there are only symptoms of problems with paying attention and few difficulties with hyperactivity, Attention Deficit Disorder (ADD) is diagnosed. The symptoms of ADHD are present from a young age and most people are diagnosed between 6 and 12 years of age.
Attention Deficit Hyperactivity Disorder (ADHD) is one of the most common childhood psychiatric disorders. It was traditionally thought that the disorder resolved during late adolescence or early adulthood. However, more recent studies have found that clinical symptoms and psychosocial impairments persist and by age 25 years 15% retain the full diagnosis with a further 50% in partial remission.
Difficulties in recognising adult ADHD can arise due to differences in symptomatology across the life-span, presence of co-morbid mental health disorders, stigma or a lack of services.
New ADHD Assessment
What to Expect on the Day of Assessment
The initial assessment will take approximately two hours and is conducted by a consultant psychiatrist. This assessment will include a complete review of ADHD related difficulties and symptoms, personal, psychiatric and medical history (including a personal or family history of heart disease), neurodevelopmental history and mental health evaluation.
You will be asked to complete a number of screening and information questionnaires prior to the appointment and during the assessment a Conner’s Adult ADHD Diagnostic Interview for DSM (CAADID) will be completed.
It would be helpful if you could bring:
· Any school reports you may have
· Previous assessment reports, such as from a psychiatrist, psychologist or paediatrician
A collateral history is usually taken on the day of your assessment, from a parent or someone who knew you well when you were a child. It would be helpful if they can accompany you to the assessment.
Sometimes the assessment process takes more than one meeting and you may meet more than one member of the adult ADHD team, such as the psychiatrist, psychologist or occupational therapist.
The clinical assessment information and results of the structured assessment, alongside referral information and additional reports are collated by your psychiatrist to reach a diagnostic opinion. These findings will be discussed with you after the assessment process by your psychiatrist. During this session you will be told if you have adult ADHD or not.
If you have adult ADHD you will be told about the treatment options available in the Adult ADHD Service. These options include further information about what ADHD is and straightforward things to help you manage your difficulties, as well as medication and psychological therapy options.
If you do not have adult ADHD you will be advised where you can go for further help and support. This may include returning to your GP for onward referral to a local adult psychiatrist or other clinical discipline.
Previous ADHD diagnosis
If you have previously had an ADHD diagnostic assessment:
If you have a previous diagnosis of ADHD and wish to attend Core Clinical for a consultation regarding medication, therapy or supports, we will require a copy of your previous diagnostic report.
Many people will have received a copy of this report at the time of diagnostic assessment. If you do not have a copy, we suggest you contact the service who completed your assessment or ask your GP if they have a copy.
This report can be sent in at the same time as your referral letter (by your GP) or you can send it yourself to email@example.com and Margaret will ensure it is linked to your referral information.
Core Clinical Adult ADHD Service provides structured assessment and evidence-based multi-modal interventions to adults with suspected or previously-diagnosed ADHD.
We are happy to discuss with you both pharmacological and non-pharmacological treatment options available for ADHD, the risks and benefits of each approach and to assist you in reaching a decision regarding the best option for you. Not all patients diagnosed with ADHD require follow-up or intervention services but where follow-up is appropriate and required it will be offered. After a period, many patients return to their GP and attend Core Clinical for yearly medication review in line with international best practice guidelines.